
BTSG Stock Forecast & Price Target
BTSG Analyst Ratings
Bulls say
BrightSpring Health is a promising investment due to its strong leadership, track record of success, and plans for growth through acquisitions and expansion into new markets. With a focus on high-acuity and high-cost patients, they are well-positioned to capitalize on their strong relationships with manufacturers and drive profitability. Their use of data and AI to improve consumer experience also bodes well for future success.
Bears say
BrightSpring Health is facing challenges with declining gross profit per prescription and pressure on pricing. They plan to address this through opportunistic buying and cost-reduction measures through technology, mergers and acquisitions. Despite their unique position in the specialty drug market, the recent acquisition of Home Health and Hospice assets may pose integration risks, and their heavy reliance on the Pharmacy Solutions segment may lead to volatility in revenue growth and EBITDA.
This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.
BTSG Analyst Forecast & Price Prediction
Start investing in BTSG
Order type
Buy in
Order amount
Est. shares
0 shares